US8816242098 - ADR
NYSE:TEVA (2/1/2023, 10:39:06 AM)+0.02 (+0.14%)
|GICS Sector||Health Care|
|Earnings (Last)||11-03 2022-11-03/dmh||Earnings (Next)||02-07 2023-02-07|
|Ins Owners||0.45%||Inst Owners||47.19%|
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
TEVA PHARMACEUTICAL-SP ADR
5 Bazel St, P O B 3190
Petah Tikva 49131
CEO: Kare Schultz
Evoke Pharma (EVOK) stock rose ~4% on Monday after the company said that a joint stipulation of dismissal was filed in the Gimoti's patent infringement case in the U.S
Stocks reacted well to uneven earnings and economic reports.
Things aren't as bad as they might seem.
I own all six great businesses and don't plan to sell a single share.
Catalyst is adding to its portfolio with a $160 million deal.
Here you can normally see the latest stock twits on TEVA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.